About this trial
The aim of this study is to determine if oocyte sorting for group culture using an artificial intelligence image analysis tool (MagentaTM) increases the usable blastocyst yield and subsequent pregnancy in patients undergoing IVF.
Eligibility criteria
Qualifiers
Fresh MII oocytes
ICSI cycles with patient's or donor's sperm
Patient's or donor's oocytes
Full IVF cycle information available (including total number of oocytes retrieved, total MII oocytes, fertilization, embryo and blastocyst development, as well as ploidy status or implantation results, and 6-7 week ultrasound, if applicable)
Disqualifiers
Severe male factor infertility (<1 million motile), including surgically retrieved sperm.
ICSI cycles inseminating in vitro matured (IVM) oocytes
Rescue ICSI oocytes (oocytes failed standard IVF and are re-inseminated by ICSI)
Low quality images - Poor quality images on day of upload or before unblinding
Trial design
Treatments tested in this trial
- Magenta AI image analysis tool
Treatment groups
Sponsors and collaborators
Ovation Fertility
Lead sponsor
Future Fertility Inc.
Collaborator